FDA Inspection 1278863 — Stacey Kiat Hong Tay
The FDA completed an inspection of Stacey Kiat Hong Tay on Jul 18, 2025 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Singapore (Singapore)
Additional Details
Clinical Investigator (CI)